For example, GLP-1R/GIPR dual agonists have demonstrated superior glucose-lowering and weight-loss effects in the treatment of diabetes and obesity
Several clinical trials have not shown a reduction of IAH by using CGM despite a reduced incidence of Level 3 hypoglycaemia [101, 112, 124, 126,127,128]
SMGT-GLP-1 Nano Microneedle Patch has been certified by multiple national authorities
My concern is the habitual, long-term use and overutilization of prescription medication based on a lack of health literacy of the patient and, quite frankly, many of the doctors who prescribe medication
The rate of dropout in studies of oral semaglutide has been significant, approximately 25% in recent trials, reflecting tolerability concerns, mainly due to nausea (source)
The Bridge program was initially planned to last six months after that, the idea was to launch a longer-term program that would shift the cost of the drugs from the government to insurers